| 产品描述: | Poloxin is a non-ATP competitive Polo-like Kinase 1 (PLK1) inhibitor that targets the polo-box domain, with an IC50 of appr 4.8 μM. |
| 靶点: |
PLK1 PBD:4.8 μM (IC50);PLK2 PBD:18.7 μM (IC50);PLK3 PBD:53.9 μM (IC50);PLK |
| 体内研究: |
Poloxin (40 mg/kg) decreases the proliferation of MDA-MB-231 cells, and surpresses the growth of the tumor nude mice bearing established xenografts of MDA-MB-231 |
| 参考文献: |
1. Yuan J, et al. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol. 2011 Oct;179(4):2091-9. 2. Sanhaji M, et al. p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors. Cell Cycle. 2012 Feb 1;11(3):543-53. 3. Lee KS, et al. Pinning down the polo-box domain. Chem Biol. 2008 May;15(5):415-6. 4. Reindl W, et al. Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions. Chem Biol. 2008 May;15(5):459-66. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.363 ml |
16.815 ml |
33.63 ml |
| 5 mM |
0.673 ml |
3.363 ml |
6.726 ml |
| 10 mM |
0.336 ml |
1.682 ml |
3.363 ml |
| 50 mM |
0.067 ml |
0.336 ml |
0.673 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |